What is the Projected CAGR value of the Thalassemia Treatment Market ?
Thalassemia Treatment Market is expected to grow at a CAGR of 10.5% during the forecast period 2024-2031.
Who are the key players in Thalassemia Treatment Market ?
Major players are Vifor Pharma, Kiadis Pharma, Gamida Cell, ApoPharma, bluebird bio, Inc., Novartis AG, Bristol-Myers Squibb Company, Celgene Corporation, La Jolla Pharmaceutical, Sangamo Biosciences, and Acceleron Pharma.